690 related articles for article (PubMed ID: 32384043)
1. A Patent Review on Nanotechnology-Based Nose-to-Brain Drug Delivery.
Singh R; Brumlik C; Vaidya M; Choudhury A
Recent Pat Nanotechnol; 2020; 14(3):174-192. PubMed ID: 32384043
[TBL] [Abstract][Full Text] [Related]
2. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
[TBL] [Abstract][Full Text] [Related]
3. Nanobiotechnology-based drug delivery in brain targeting.
Dinda SC; Pattnaik G
Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
[TBL] [Abstract][Full Text] [Related]
4. Recent patents review on intranasal administration for CNS drug delivery.
Jogani V; Jinturkar K; Vyas T; Misra A
Recent Pat Drug Deliv Formul; 2008; 2(1):25-40. PubMed ID: 19075895
[TBL] [Abstract][Full Text] [Related]
5. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
Pardeshi CV; Belgamwar VS
Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy.
Khatri DK; Preeti K; Tonape S; Bhattacharjee S; Patel M; Shah S; Singh PK; Srivastava S; Gugulothu D; Vora L; Singh SB
Curr Neuropharmacol; 2023; 21(3):493-516. PubMed ID: 35524671
[TBL] [Abstract][Full Text] [Related]
7. Current Nanoparticle Approaches in Nose to Brain Drug Delivery and Anticancer Therapy - A Review.
Ansari MA; Chung IM; Rajakumar G; Alzohairy MA; Alomary MN; Thiruvengadam M; Pottoo FH; Ahmad N
Curr Pharm Des; 2020; 26(11):1128-1137. PubMed ID: 31951165
[TBL] [Abstract][Full Text] [Related]
8. Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose-Brain Drug Delivery.
Taha E; Shetta A; Nour SA; Naguib MJ; Mamdouh W
Mol Pharm; 2024 Mar; 21(3):999-1014. PubMed ID: 38329097
[TBL] [Abstract][Full Text] [Related]
9. CNS drug delivery systems: novel approaches.
Pathan SA; Iqbal Z; Zaidi SM; Talegaonkar S; Vohra D; Jain GK; Azeem A; Jain N; Lalani JR; Khar RK; Ahmad FJ
Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):71-89. PubMed ID: 19149731
[TBL] [Abstract][Full Text] [Related]
10. Lipid Nanocarriers for Neurotherapeutics: Introduction, Challenges, Blood-brain Barrier, and Promises of Delivery Approaches.
Aslam M; Javed MN; Deeb HH; Nicola MK; Mirza MA; Alam MS; Akhtar MH; Waziri A
CNS Neurol Disord Drug Targets; 2022; 21(10):952-965. PubMed ID: 34967302
[TBL] [Abstract][Full Text] [Related]
11. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
Kanazawa T
Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases.
Huang Q; Chen Y; Zhang W; Xia X; Li H; Qin M; Gao H
J Control Release; 2024 Feb; 366():519-534. PubMed ID: 38182059
[TBL] [Abstract][Full Text] [Related]
13. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
[TBL] [Abstract][Full Text] [Related]
14. Recent Patents Concerning the use of Nanotechnology-based Delivery Systems as Skin Penetration Enhancers.
Medeiros-Neves B; Nemitz MC; Silveira Fachel FN; Teixeira HF
Recent Pat Drug Deliv Formul; 2019; 13(3):192-202. PubMed ID: 31696814
[TBL] [Abstract][Full Text] [Related]
15. Recent Trends in Nanotechnology-Based Drugs and Formulations for Targeted Therapeutic Delivery.
Iqbal HMN; Rodriguez AMV; Khandia R; Munjal A; Dhama K
Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):86-93. PubMed ID: 27978790
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles for direct nose-to-brain delivery of drugs.
Mistry A; Stolnik S; Illum L
Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
[TBL] [Abstract][Full Text] [Related]
17. Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders.
Agosti E; Zeppieri M; Antonietti S; Battaglia L; Ius T; Gagliano C; Fontanella MM; Panciani PP
Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543223
[TBL] [Abstract][Full Text] [Related]
18. Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review.
Kulkarni AD; Vanjari YH; Sancheti KH; Belgamwar VS; Surana SJ; Pardeshi CV
J Drug Target; 2015; 23(9):775-88. PubMed ID: 25758751
[TBL] [Abstract][Full Text] [Related]
19. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
Meng J; Agrahari V; Youm I
J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
[TBL] [Abstract][Full Text] [Related]
20. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
